Voyager therapeutics, inc. (VYGR)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Dec'14
Assets
Current assets:
Cash and cash equivalents

165,227

86,042

82,640

79,885

113,261

46,859

42,142

59,614

140,371

31,530

48,201

66,300

43,604

36,641

63,507

67,032

33,895

31,309

7,035

Marketable securities, current

85,704

195,491

224,760

247,577

245,238

108,947

137,459

136,509

77,827

137,522

77,386

75,023

114,066

137,777

127,646

136,961

170,097

163,028

-

Related party collaboration receivable

16,283

18,496

11,733

8,242

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unbilled accounts receivable

-

-

2,300

1,821

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

5,262

4,630

6,164

3,250

6,668

6,675

2,865

4,122

2,433

2,738

2,604

3,403

3,410

4,368

1,868

1,484

1,706

1,557

1,323

Total current assets

272,476

304,659

327,597

340,775

365,167

162,481

182,466

200,245

220,631

171,790

128,191

144,726

161,080

178,786

193,021

205,477

205,698

195,894

8,358

Property and equipment, net

18,586

17,986

15,292

14,493

13,146

12,771

12,527

12,244

11,458

10,283

10,558

10,674

10,134

7,893

4,253

3,603

3,558

3,234

2,804

Deposits and other non-current assets

2,378

1,723

1,976

2,003

1,462

1,149

1,271

1,314

1,617

1,304

1,206

1,534

1,876

1,527

2,294

735

735

321

335

Marketable securities, non-current

1,432

1,920

2,024

1,280

1,280

628

800

860

1,320

1,100

960

1,480

2,000

1,360

2,416

-

9,989

30,008

-

Operating lease, right-of-use asset

27,738

28,472

29,331

30,041

30,294

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total assets

322,610

354,760

376,220

388,592

411,349

177,029

197,064

214,663

235,026

184,477

140,915

158,414

175,090

189,566

201,984

209,815

219,980

229,457

11,497

Liabilities and stockholders' equity
Current liabilities:
Accounts payable

4,815

4,070

4,026

2,230

2,261

1,038

1,422

1,558

1,372

1,020

911

307

557

550

787

454

1,697

612

1,554

Accrued expenses

17,493

21,516

16,588

11,782

9,276

9,788

8,355

7,697

9,351

11,497

10,493

7,314

5,593

6,488

6,304

5,049

2,661

3,430

642

Other current liabilities

3,306

3,193

3,016

2,843

2,673

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, current

46,923

47,233

56,542

52,291

44,566

20,847

20,250

19,840

20,217

3,380

9,537

4,215

4,914

6,764

12,296

14,257

18,719

19,589

-

Deferred rent, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

300

278

Total current liabilities

72,537

76,012

80,172

69,146

58,776

31,673

30,027

29,095

30,940

15,897

20,941

11,836

11,064

13,802

19,387

19,760

23,077

23,931

2,474

Deferred rent

-

-

-

-

-

-

5,642

5,282

5,279

5,337

5,385

5,430

5,058

4,999

1,988

1,390

1,352

1,015

1,314

Deferred revenue, non-current

139,227

147,260

155,093

167,436

217,483

92,199

94,804

97,308

99,506

28,180

28,368

34,838

35,248

34,818

31,456

32,927

31,914

35,393

-

Other non-current liabilities

31,089

31,976

32,799

33,606

34,396

6,711

1,003

1,006

1,008

1,012

1,015

1,019

1,023

25

29

34

40

44

255

Warrants and Rights Outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,305

Total liabilities

242,853

255,248

268,064

270,188

310,655

130,583

131,476

132,691

136,733

50,426

55,709

53,123

52,393

53,644

52,860

54,111

56,383

60,383

10,348

Commitments and contingencies (see note 8)

-

-

-

-

-

-

0

-

0

-

-

-

-

-

-

-

-

-

-

Stockholders' equity:
Preferred stock $0.001 par value: 5,000,000 shares authorized at March 31, 2020 and December 31, 2019; no shares issued and outstanding at March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

-

0

-

-

-

-

0

-

-

-

-

-

Common stock, $0.001 par value: 120,000,000 shares authorized at March 31, 2020 and December 31, 2019; 36,976,751 and 36,575,983 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

37

37

37

37

37

32

32

32

32

32

26

26

26

26

25

25

25

25

1

Additional paid-in capital

416,210

412,227

408,208

403,334

396,953

315,598

312,250

308,296

299,112

295,019

234,519

230,773

229,009

225,963

223,811

221,964

220,552

219,122

-

Accumulated other comprehensive income (loss)

421

-104

-15

101

-75

-133

-174

-125

-162

-287

-455

30

325

-52

630

60

30

-251

-

Accumulated deficit

-336,900

-312,648

-300,100

-285,100

-296,221

-269,051

-246,520

-226,231

-200,689

-160,713

-148,884

-125,538

-106,663

-90,015

-75,342

-66,345

-57,010

-49,822

-20,831

Total stockholders' equity

79,757

99,512

108,156

118,404

100,694

46,446

65,588

81,972

98,293

134,051

85,206

105,291

122,697

135,922

149,124

155,704

163,597

169,074

-20,830

Total liabilities and stockholders' equity

322,610

354,760

376,220

388,592

411,349

177,029

197,064

214,663

235,026

184,477

140,915

158,414

175,090

189,566

201,984

209,815

219,980

229,457

11,497